Suberoylanilide hydroxamic acid blocks self-renewal and homotypic aggregation of inflammatory breast cancer spheroids

Cancer

Volumn 116, Issue SUPPL. 11, 2010, Pages 2760-2767

  Robertson, Fredika M ^a   Woodward, Wendy A ^a   Pickei, Ross ^a   Ye, Zaiming ^a   Bornmann, William ^a   Pal, Ashutosh ^a   Peng, Zhenghong ^a   Hall, Carolyn S ^a   Cristofanilli, Massimo ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Cancer stem cells; E cadherin; Histone deacetylase enzymes; Homotypic aggregation; Inflammatory breast cancer; SAHA; Self renewal; Suberoylanilide hydroxamic acid

Indexed keywords

HISTONE DEACETYLASE; UVOMORULIN; VORINOSTAT;

ADVANCED CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL AGGREGATION; CELL FRACTIONATION; CELL INVASION; CELL RENEWAL; CELL STRAIN; CELL STRAIN MCF 7; CELL STRAIN SUM 149; CELL STRAIN SUM 190; CLONOGENIC ASSAY; CONFERENCE PAPER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG MECHANISM; DRUG TARGETING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IC 50; INFLAMMATORY BREAST CANCER; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SKIN METASTASIS; TUMOR EMBOLISM; TUMOR SPHEROID; WESTERN BLOTTING; ANTINEOPLASTIC ACTIVITY; ARTICLE; BASEMENT MEMBRANE; CONCENTRATION RESPONSE; HUMAN CELL CULTURE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CADHERINS; CELL AGGREGATION; CELL DIVISION; CELL LINE, TUMOR; DRUG EVALUATION, PRECLINICAL; FEMALE; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; INFLAMMATION; NEOPLASM INVASIVENESS; SPHEROIDS, CELLULAR;

EID: 77952689822     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25176     Document Type: Conference Paper

References (14)

1. Singletary SE, Cristofanilli M. Defining the clinical diagnosis of inflammatory breast cancer. Semin Oncol. 2008;35:7-10. (Pubitemid 351282390)
2. Cristofanilli M, Valero V, Buzdar AU, et al. Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease. Cancer. 2007;110:1436-1444.
3. Alpaugh ML, Tomlinson JS, Ye Y, Barsky SH. Relationship of sialyl-Lewis(x/a) underexpression and E-cadherin overexpression in the lymphovascular embolus of inflammatory breast carcinoma. Am J Pathol. 2002;161:619-628. (Pubitemid 36142170)
4. Liu Y, Wang Y, Zhang Y, et al. Abnormal expression of p120-catenin, E-cadherin, and small GTPases is significantly associated with malignant phenotype of human lung cancer. Lung Cancer. 2009;63:375-382.
5. Xiao Y, Ye Y, Yearsley K, Jones S, Barsky SH. The lymphovascular embolus of inflammatory breast cancer expresses a stem cell-like phenotype. Am J Pathol. 2008; 173:561-574.
6. Lee MJ, Kim YS, Kummar S, Giaccone G, Trepel JB. Histone deacetylase inhibitors in cancer therapy. Curr Opin Oncol. 2008;20:639-649.
7. Xu WS, Parmigiani RB, Marks PA. Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene. 2007; 26:5541-5552. (Pubitemid 47255934)
8. Mann BS, Johnson JR, Cohen MH, Justice R, Pazdur R. FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma. Oncologist. 2007;12:1247-1252. (Pubitemid 350106355)
9. Duvic M, Vu J. Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma. Expert Opin Investig Drugs. 2007;16:1111-1120. (Pubitemid 47074165)
10. Luu TH, Morgan RJ, Leong L, et al. A phase II trial of vorinostat (suberoylanilide hydroxamic acid) in metastatic breast cancer: a California Cancer Consortium study. Clin Cancer Res. 2008;14:7138-7142.
11. Ethier SP. Human breast cancer cell lines as models of growth regulation and disease progression. J Mammary Gland Biol Neoplasia. 1996;1:111-121.
12. Forozan F, Mahlamaki EH, Monni O, et al. Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res. 2000;60:4519-4525.
13. Dontu G, Abdallah WM, Foley JM, et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 2003;17:1253-1270.
14. Dontu G, Wicha MS. Survival of mammary stem cells in suspension culture: implications for stem cell biology and neoplasia. J Mammary Gland Biol Neoplasia. 2005;10:75-86. (Pubitemid 40724024)